UNSPSC 51294520: Paroxetine hydrochloride hemihydrate

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent 2C19H20FNO3.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X2ELS050D8, chemically known as (-)-(3s,4r)-4-(p-fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)-methyl)piperidine hydrochloride hemihydrate, but more generally known as paroxetine hydrochloride hemihydrate, which bears US NIH Compound Identifier 62878.

UNSPSC 51294520 Paroxetine hydrochloride hemihydrate is a Commodity code covering pharmaceutical products, though the recent state and local solicitation activity under this code shows a substantial mismatch with the nominal scope. The single recent opportunity posted under this code — Seminole County, Florida's IFB 60459723LAS — sought procurement of naloxone and safe drug deactivation systems for community health initiatives, not paroxetine or selective serotonin reuptake inhibitors. The solicitation represents a county health department purchasing narcotics-reversal agents and drug-disposal equipment rather than psychiatric medications aligned with the code's stated commodity name.

Seminole County, Florida issued the IFB on June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, to be delivered quarterly to the Seminole County Community Health Building in Sanford. The code shows minimal recent activity under its pharmaceutical scope, and the single opportunity tracked here suggests either a tagging error in the state procurement system or a divergence between the UNSPSC nomenclature and actual acquisition practice in Florida's Seminole County. No other state or local jurisdictions appear in the recent opportunities block. Without additional solicitations aligned to the paroxetine or antidepressant scope, the code's relevance to pharmaceutical vendor pursuit in state and local markets remains unclear.